Literature DB >> 21685428

Behavioral activation and therapeutic exposure for bereavement in older adults.

Ron Acierno1, Alyssa Rheingold, Ananda Amstadter, Jerome Kurent, Elaine Amella, Heidi Resnick, Wendy Muzzy, Carl Lejuez.   

Abstract

The development and clinical trial of a 5-session behavioral intervention for complicated bereavement (CB) is presented. We conceptualized CB in terms of Major Depression (MDD) and Post-traumatic Stress Disorder (PTSD) and consequently applied treatment components of Behavioral Activation and Therapeutic Exposure (BA-TE). In order to assure standardization of treatment, control costs, and engage patients, a multi-media, multi-context format was adopted to address avoidance and withdrawal behaviors conceptualized as central pathogenic responses in CB. Participants (N = 26) were assessed before and after BA-TE treatment via structured clinical interview and standardized questionnaires in terms of PTSD, MDD, CB, and health concerns. The number of days since the death of the loved one was widely variable and served as a covariate for all outcome analyses. ANCOVAS revealed statistically significant improvement, irrespective of how many days since death had elapsed prior to initiation of intervention, on structured interviews and self-report measures for most outcome variables.

Entities:  

Mesh:

Year:  2011        PMID: 21685428     DOI: 10.1177/1049909111411471

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  14 in total

1.  Behavioral activation for depression in older adults: theoretical and practical considerations.

Authors:  Courtney Allyn Polenick; Stephen Ray Flora
Journal:  Behav Anal       Date:  2013

2.  A randomized controlled trial of an internet-based therapist-assisted indicated preventive intervention for prolonged grief disorder.

Authors:  Brett T Litz; Yonit Schorr; Eileen Delaney; Teresa Au; Anthony Papa; Annie B Fox; Sue Morris; Angela Nickerson; Susan Block; Holly G Prigerson
Journal:  Behav Res Ther       Date:  2014-07-24

3.  An Examination of Social Support and PTSD Treatment Response During Prolonged Exposure.

Authors:  Matthew Price; Cynthia Luethcke Lancaster; Daniel F Gros; Alison C Legrand; Katherine van Stolk-Cooke; Ron Acierno
Journal:  Psychiatry       Date:  2018-07-18       Impact factor: 2.458

4.  Utilization of Hospice Bereavement Support by At-Risk Family Members.

Authors:  Angela Ghesquiere; Julie Thomas; Martha L Bruce
Journal:  Am J Hosp Palliat Care       Date:  2014-10-16       Impact factor: 2.500

5.  Restorative retelling for violent loss: an open clinical trial.

Authors:  Connie Saindon; Alyssa A Rheingold; Jenna Baddeley; Meghan M Wallace; Clara Brown; Edward K Rynearson
Journal:  Death Stud       Date:  2013-11-11

Review 6.  Bereavement and complicated grief.

Authors:  M Katherine Shear; Angela Ghesquiere; Kim Glickman
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

7.  Experiential avoidance moderates the association between motivational sensitivity and prolonged grief but not posttraumatic stress symptoms.

Authors:  Joah L Williams; Madeleine M Hardt; Aisling V Henschel; Jasmine R Eddinger
Journal:  Psychiatry Res       Date:  2019-01-07       Impact factor: 3.222

8.  Restorative Retelling for Violent Death: An Investigation of Treatment Effectiveness, Influencing Factors, and Durability.

Authors:  Alyssa A Rheingold; Jenna L Baddeley; Joah L Williams; Clara Brown; Megan M Wallace; Fanny Correa; Edward K Rynearson
Journal:  J Loss Trauma       Date:  2015-01-13

9.  Integrating Motivational Interviewing and Brief Behavioral Activation Therapy: Theoretical and Practical Considerations.

Authors:  Iván C Balán; C W Lejuez; Marcela Hoffer; Carlos Blanco
Journal:  Cogn Behav Pract       Date:  2016-05

10.  Hospice Services for Complicated Grief and Depression: Results from a National Survey.

Authors:  Angela R Ghesquiere; Melissa D Aldridge; Rosemary Johnson-Hürzeler; Daniel Kaplan; Martha L Bruce; Elizabeth Bradley
Journal:  J Am Geriatr Soc       Date:  2015-10-12       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.